Predictable pharmacokinetics of ximelagatran, an oral direct thrombin inhibitor, in nonvalvular atrial fibrillation patients receiving long-term treatment - Eriksson,U.; Baathe,S.; Hamrén,B.; Wollbratt,M.; Wolzt,M.; Grind,M. (Pathophysiol Haemost Thromb, 2002)